Sunflower Pharmaceutical Group Co.,Ltd (SHE: 002737)

Market Cap	12.22B
Revenue (ttm)	5.19B
Net Income (ttm)	967.32M
Shares Out	584.00M
EPS (ttm)	1.65
PE Ratio	12.67
Forward PE	n/a
Dividend	1.50 (7.09%)
Ex-Dividend Date	Jun 14, 2024

Volume	1,993,700
Open	21.60
Previous Close	21.15
Day's Range	20.90 - 21.60
52-Week Range	20.50 - 30.79
Beta	0.30
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 25, 2024

About Sunflower Pharmaceutical Group Co.,Ltd

Sunflower Pharmaceutical Group Co.,Ltd engages in the research and development, manufacturing, and marketing of Chinese patent medicines in China and internationally. The company produces chemical and biological medicines, and health care products. It also provides products covering various therapeutic areas, including pediatrics, gynecology, digestive system, respiratory and cold, rheumatic bone disease, and cardiovascular and cerebrovascular; supplements; and antibiotics and children’s medicinal products. The company sells its products under ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2005
• Employees: 5,776
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002737

Financial Performance

In 2023, Sunflower Pharmaceutical Group Co.,Ltd's revenue was 5.70 billion, an increase of 11.89% compared to the previous year's 5.09 billion. Earnings were 1.12 billion, an increase of 29.05%.